Bio Protocol has officially launched its PEPTAI token on the Base chain, marking a significant milestone in decentralized science (DeSci) by activating an AI agent dedicated to peptide drug discovery.
Token Allocation and Claim Mechanics
The PEPTAI token is available for claim via the Bio App. According to the official announcement, 20% of the total supply is allocated to BIO token stakers (veBIO holders). This allocation is vested over six months, with 20% available at the token generation event (TGE). Early full claiming incurs penalties on the unvested portion.
Market Performance and Volatility Warning
Following its listing, PEPTAI's market capitalization briefly exceeded $15 million within five minutes, before stabilizing at around $13.5 million with a trading volume of $2.2 million. Investors are advised to exercise caution due to the high volatility of token prices.
DeSci Ecosystem Innovation with AI
Bio Protocol aims to advance scientific research through decentralization. By integrating an AI agent for peptide drug discovery, the project leverages blockchain transparency and incentive mechanisms to accelerate drug development. Analysts see such AI-DeSci hybrids as potential new paradigms for biotech funding and collaboration.
Notably, other DeSci projects like Manadia & NanoVita's partnership and RoyalPop's smart money inflows reflect growing interest in this sector. However, PEPTAI's status as the first AI-integrated token from Bio Protocol on Base Chain gives it a first-mover advantage.